Literature DB >> 8778068

Cicatricial pemphigoid: diagnosis and treatment.

Q D Nguyen1, C S Foster.   

Abstract

Cicatricial pemphigoid is a systemic autoimmune disease with both ocular and extraocular manifestations. Its effect on the eyes is characterized by chronic cicatrizing conjunctivitis and progressive conjunctival sub-epithelial fibrosis with resultant fornix foreshortening, symblepharon formation, trichiasis, meibomian, and lacrimal duct obstruction resulting in sicca syndrome, ocular surface keratinization, and eventually blindness. Extraocular manifestations include stricture formation of the esophagus, trachea, anus, or vagina. OCP is characterized by deposition of immunoreactants at the conjunctival basement membrane zone, initiating a type II hypersensitivity reaction. Demonstration of this deposition can be done using immunofluorescence or immunoperoxidase technique.

Entities:  

Mesh:

Year:  1996        PMID: 8778068     DOI: 10.1097/00004397-199603610-00007

Source DB:  PubMed          Journal:  Int Ophthalmol Clin        ISSN: 0020-8167


  5 in total

1.  Mucous Membrane Pemphigoid Causing Central Airway Obstruction.

Authors:  Bilal A Jalil; Yara G Abdou; Stephanie A Rosen; Tarek Dammad
Journal:  J Bronchology Interv Pulmonol       Date:  2017-10

2.  Localized Blistering Eruption of the Face and Neck - A Case Study and Differential Considerations.

Authors:  Małgorzata Michalska-Jakubus; Anita Wdowiak-Filip; Cezary Kowalewski; Katarzyna Woźniak; Dorota Krasowska
Journal:  Clin Cosmet Investig Dermatol       Date:  2022-02-19

3.  The management of oral pemphigus vulgaris with systemic corticosteroid and dapsone.

Authors:  Arash Azizi; Shirin Lawaf
Journal:  J Dent Res Dent Clin Dent Prospects       Date:  2008-05-15

4.  Mucous Membrane Pemphigoid with Tracheal Involvement.

Authors:  Arash Minaie; Salim R Surani
Journal:  Case Rep Pulmonol       Date:  2016-02-03

5.  DNA methyltransferase inhibitor suppresses fibrogenetic changes in human conjunctival fibroblasts.

Authors:  Hitomi Yonemura; Akiko Futakuchi; Miyuki Inoue-Mochita; Tomokazu Fujimoto; Eri Takahashi; Hidenobu Tanihara; Toshihiro Inoue
Journal:  Mol Vis       Date:  2019-07-21       Impact factor: 2.367

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.